Literature DB >> 16115630

Epac1 regulates integrity of endothelial cell junctions through VE-cadherin.

Matthijs R H Kooistra1, Monica Corada, Elisabetta Dejana, Johannes L Bos.   

Abstract

We have previously shown that Rap1 as well as its guanine nucleotide exchange factor Epac1 increases cell-cell junction formation. Here, we show that activation of Epac1 with the exchange protein directly activated by cAMP (Epac)-specific cAMP analog 8CPT-2'O-Me-cAMP (007) resulted in a tightening of the junctions and a decrease in the permeability of the endothelial cell monolayer. In addition, 007 treatment resulted in the breakdown of actin stress fibers and the formation of cortical actin. These effects were completely inhibited by siRNA against Epac1. In VE-cadherin knock-out cells Epac1 did not affect cell permeability, whereas in cells re-expressing VE-cadherin this effect was restored. Finally, the effect of Epac activation on the actin cytoskeleton was independent of junction formation. From these results we conclude that in human umbilical vein endothelial cells Epac1 controls VE-cadherin-mediated cell junction formation and induces reorganization of the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115630     DOI: 10.1016/j.febslet.2005.07.080

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  147 in total

1.  Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.

Authors:  Cristina Hernández; Patricia Bogdanov; Cristina Solà-Adell; Joel Sampedro; Marta Valeri; Xavier Genís; Olga Simó-Servat; Marta García-Ramírez; Rafael Simó
Journal:  Diabetologia       Date:  2017-08-04       Impact factor: 10.122

Review 2.  Regulation of the inflammatory response of vascular endothelial cells by EPAC1.

Authors:  Euan Parnell; Brian O Smith; Timothy M Palmer; Anna Terrin; Manuela Zaccolo; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

4.  A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting.

Authors:  Hui Jin; Barbara Garmy-Susini; Christie J Avraamides; Konstantin Stoletov; Richard L Klemke; Judith A Varner
Journal:  Blood       Date:  2010-09-08       Impact factor: 22.113

Review 5.  The NO cascade, eNOS location, and microvascular permeability.

Authors:  Walter N Durán; Jerome W Breslin; Fabiola A Sánchez
Journal:  Cardiovasc Res       Date:  2010-05-11       Impact factor: 10.787

6.  Small Rho GTPase-mediated actin dynamics at endothelial adherens junctions.

Authors:  Jaap D van Buul; Ilse Timmerman
Journal:  Small GTPases       Date:  2016-01-29

7.  Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration.

Authors:  Eric A Severson; Winston Y Lee; Christopher T Capaldo; Asma Nusrat; Charles A Parkos
Journal:  Mol Biol Cell       Date:  2009-01-28       Impact factor: 4.138

Review 8.  Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors.

Authors:  George G Holz; Oleg G Chepurny; Frank Schwede
Journal:  Cell Signal       Date:  2007-07-25       Impact factor: 4.315

9.  Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice.

Authors:  Magdalena Chrzanowska-Wodnicka; Anna E Kraus; Daniel Gale; Gilbert C White; Jillian Vansluys
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

10.  Lung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling.

Authors:  Anna A Birukova; Panfeng Fu; Junjie Xing; Ivan Cokic; Konstantin G Birukov
Journal:  Transl Res       Date:  2010-01       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.